Texas Halo Fund has surpassed its funding goal and is closing its 2018 funding round on December 31st. The 2018 Fund is the latest in Texas Halo Fund series that began in 2012. The Fund was created to give accredited investors easy access to the potentially high returns available in early stage, “angel” investments. Texas Halo Fund has over $10 million in committed capital under management. The Fund launched this series in early 2018 and is committed to Houston’s burgeoning business startup ecosystem with successive, annual funds.
Texas Halo Fund will launch its 2019 fund early next year. Strong investor demand, active regional support, and significant growth of investment opportunities in the Texas startup ecosystem are driving this promising alternative financial sector. While the Fund has a nationwide scope benefiting investors, the Managing Directors emphasize investments in Houston-based and Texas-centric startup companies, thereby supporting economic growth, municipal objectives and regional diversification.
The Texas Halo Fund is the largest diversified, early stage angel venture fund in the Houston area. The fund aims to build a portfolio of 20-30 investments to reduce investor risk. Investments are made across diverse, uncorrelated industry sectors addressing issues investors face when pursuing early stage investing such as securing adequate deal flow, having ample time for appropriate due diligence, and ensuring diversification.
Leadership of the current Texas Halo Fund offering is made up of four Managing Directors with diverse backgrounds and years of experience in early stage investing. Their combined experience is pooled to screen opportunities, perform due diligence on candidate deals, and set investment amounts. After an investment is funded and becomes a portfolio company, the Fund’s Directors stay actively involved, supporting the companies’ success for the benefit of fund investors.
To date, the 2018 Fund has invested in 9 start-up companies, including sector investments in life science, technology, consumer products, and services. Fund portfolio companies include:
GlycosBio Food Science uses proprietary biochemistry to produce high calorie nutrition benefiting patients with intestinal absorption issues, a cause of malnutrition. Potential applications include patients with compromised pancreatic function, the very young, the elderly, and cancer patients in need of supplemental calories.
Your Fare aggregates delivery and take-out orders from services such as GrubHub, PostMates, and UberEats, and delivers the orders to restaurants on a single tablet device or directly to the restaurants Point of Sale system.
ScribeRule provides software solutions to protect sensitive documents from unauthorized access, while permitting secure collaboration. With initial customers in the United States Federal Government, the company provides a comprehensive solution for document security.
By investing in the Fund, individual investors broaden their portfolio in a fraction of the time and with less outlay than they would if investing independently. In addition, investors are provided due diligence reports on each of the Fund’s investments which investors can often use to make further direct investments.
Leave a Comment
You must be logged in to post a comment.